Artelo Biosciences (ARTL) Proxy filing summary

Executive summary

• Annual Meeting of Shareholders scheduled for July 17, 2026, to be held virtually.

• Shareholders are urged to submit proxies in advance to help establish quorum and ensure efficient meeting proceedings.

• Participation is encouraged regardless of voting direction, as quorum is essential for conducting business.

• Forward-looking statements address product development, clinical and regulatory timelines, and growth opportunities.

Voting matters and shareholder proposals

• Board has recommended votes on each proposal described in the proxy statement.

• Shareholders are encouraged to review proxy materials carefully before voting.

Board of directors and corporate governance

• Board emphasizes the importance of shareholder participation to achieve quorum and avoid meeting adjournment.